WallStreetZenWallStreetZen

NASDAQ: BTCY
Biotricity Inc Stock Ownership - Who owns Biotricity?

Insider buying vs selling

Have Biotricity Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BTCY insiders and whales buy or sell their stock.

BTCY Shareholders

What type of owners hold Biotricity Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Waqaas Alsiddiq50.89%4,712,336$5.98MInsider
Norman M. Betts4.06%375,598$477.01kInsider
Patricia J. Kennedy2.70%250,000$317.50kInsider
David A. Rosa1.64%152,174$193.26kInsider
Vanguard Group Inc1.11%102,576$130.27kInstitution
Geode Capital Management LLC0.69%64,074$81.37kInstitution
Strengthening Families Communities LLC0.52%48,263$61.29kInstitution
Ae Wealth Management LLC0.45%41,684$52.94kInstitution
John Ayanoglou0.45%41,667$52.92kInsider
State Street Corp0.24%22,548$28.64kInstitution

1 of 3

BTCY vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTCY3.96%59.75%
DHAI11.08%88.92%
BMRA22.27%34.05%Net Buying
QTI8.17%91.83%Net BuyingNet Buying
NXL0.65%32.87%

Biotricity Stock Ownership FAQ

Who owns Biotricity?

Biotricity (NASDAQ: BTCY) is owned by 3.96% institutional shareholders, 59.75% Biotricity insiders, and 36.29% retail investors. Waqaas Alsiddiq is the largest individual Biotricity shareholder, owning 4.71M shares representing 50.89% of the company. Waqaas Alsiddiq's Biotricity shares are currently valued at $6.97M.

If you're new to stock investing, here's how to buy Biotricity stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.